Table of Content

1. Introduction
1.1. Product Definition
1.2. Research Process
1.3. Assumptions
1.4. Market Definition

2. Preface

3. Executive Summary

4. Impact of COVID-19 on Europe Veterinary Vaccines Market

5. Europe Veterinary Vaccines Market Outlook 2016-2026F
5.1. Market Size & Analysis
5.1.1. By Revenues
5.2. Market Share & Analysis
5.2.1. By Animal Vaccine Type
5.2.1.1. Livestock Vaccines
5.2.1.1.1. Bovine Vaccines
5.2.1.1.2. Poultry Vaccines
5.2.1.1.3. Porcine Vaccines
5.2.1.1.4. Other Livestock Vaccines
5.2.1.2. Companion Animal Vaccines
5.2.1.2.1. Canine Vaccines
5.2.1.2.2. Feline Vaccines
5.2.1.2.3. Equine Vaccines
5.2.2. By Technology
5.2.2.1. Live Attenuated Vaccines
5.2.2.2. Inactivated Vaccines
5.2.2.3. Toxoid Vaccines
5.2.2.4. Recombinant Vaccines
5.2.2.5. Other (DNA Vaccines, Subunit Vaccines, Conjugate Vaccines)
5.2.3. By Disease Type
5.2.3.1. Canine Disease
5.2.3.1.1. Distemper
5.2.3.1.2. Kennel cough (Parainfluenza)
5.2.3.1.3. Parvovirus
5.2.3.1.4. Canine herpes
5.2.3.1.5. Lyme Disease
5.2.3.1.6. Rabies
5.2.3.2. Porcine Disease
5.2.3.3. Bovine Disease
5.2.3.3.1. Foot & mouth disease (FMD)
5.2.3.3.2. Lumpy skin
5.2.3.3.3. Rotavirus
5.2.3.3.4. Corona virus
5.2.3.3.5. E. Coli
5.2.3.3.6. Others
5.2.3.4. Poultry Disease
5.2.3.4.1. Infectious Bronchitis
5.2.3.4.2. Avian Influenza
5.2.3.4.3. Marek’s Disease
5.2.3.4.4. Newcastle Disease
5.2.3.4.5. Salmonella
5.2.3.5. Aquaculture Disease
5.2.3.5.1. Streptococcosis
5.2.3.5.2. Vibrio
5.2.3.5.3. Aeromonas
5.2.3.6. Other Disease Type
5.2.4. By Country
5.2.4.1. The UK
5.2.4.2. Germany
5.2.4.3. Italy
5.2.4.4. France
5.2.4.5. Spain
5.2.4.6. Others
5.2.5. By Company
5.2.5.1. Revenue Shares
5.2.5.2. Strategic Factorial Indexing
5.2.5.3. Competitor Placement in MarkNtel Quadrant

6. The UK Veterinary Vaccines Market Outlook 2016-2026F
6.1. Market Size & Analysis
6.1.1. By Revenues
6.2. Market Share & Analysis
6.2.1. By Product Form
6.2.2. By Application
6.2.3. By Disease Type

7. Germany Veterinary Vaccines Market Outlook 2016-2026F
7.1. Market Size & Analysis
7.1.1. By Revenues
7.2. Market Share & Analysis
7.2.1. By Product Form
7.2.2. By Application
7.2.3. By Disease Type

8. Italy Veterinary Vaccines Market Outlook 2016-2026F
8.1. Market Size & Analysis
8.1.1. By Revenues
8.2. Market Share & Analysis
8.2.1. By Product Form
8.2.2. By Application
8.2.3. By Disease Type

9. France Veterinary Vaccines Market Outlook 2016-2026F
9.1. Market Size & Analysis
9.1.1. By Revenues
9.2. Market Share & Analysis
9.2.1. By Product Form
9.2.2. By Application
9.2.3. By Disease Type

10. Spain Veterinary Vaccines Market Outlook 2016-2026F
10.1. Market Size & Analysis
10.1.1. By Revenues
10.2. Market Share & Analysis
10.2.1. By Product Form
10.2.2. By Application
10.2.3. By Disease Type

11. Europe Veterinary Vaccines Market Regulations

12. Europe Veterinary Vaccines Market Trends & Insights

13. Europe Veterinary Vaccines Market Dynamics
13.1. Growth Drivers
13.2. Challenges
13.3. Impact Analysis

14. Europe Veterinary Vaccines Market Hotspot and Opportunities

15. Europe Veterinary Vaccines Market Key Strategic Imperatives for Success and Growth

16. Competition Outlook
16.1. Competition Matrix
16.1.1. Target Markets
16.1.2. Target End Users
16.1.3. Research & Development
16.1.4. Strategic Alliances
16.1.5. Strategic Initiatives
16.2. Company Profiles (Business Description, Fuel Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)
16.2.1. Merck & Co. Inc.
16.2.2. Virbac SA
16.2.3. Elanco Animal Health
16.2.4. Ceva Sante Animale
16.2.5. Phibro Animal Health Corp.
16.2.6. HIPRA
16.2.7. Zoetis Inc.
16.2.8. Boehringer Ingelheim International GmbH
16.2.9. Neogen Corporation

17. Disclaimer